Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses.

MLA

Radaelli, Antonia, et al. “Different Immunogens and Prime-Boost Vaccination Strategies Affect the Efficacy of Recombinant Candidate Vaccines against Pathogenic Orthopoxviruses.” Virology Journal, vol. 21, no. 1, Nov. 2024, p. 282. EBSCOhost, https://doi.org/10.1186/s12985-024-02534-4.

APA

Radaelli, A., Zanotto, C., Brambilla, C., Adami, T., Paolini, F., Venuti, A., Manuka, A., Mehmeti, I., & De Giuli Morghen, C. (2024). Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses. Virology Journal, 21(1), 282. https://doi.org/10.1186/s12985-024-02534-4

Chicago

Radaelli, Antonia, Carlo Zanotto, Chiara Brambilla, Tommaso Adami, Francesca Paolini, Aldo Venuti, Adriana Manuka, Irsida Mehmeti, and Carlo De Giuli Morghen. 2024. “Different Immunogens and Prime-Boost Vaccination Strategies Affect the Efficacy of Recombinant Candidate Vaccines against Pathogenic Orthopoxviruses.” Virology Journal 21 (1): 282. doi:10.1186/s12985-024-02534-4.